The Recall Desk
HighFDA (Devices)·Z-0199-2024·Announced 2023-11-08

RX Daytona Plus Clinical Chemistry Analyzer Rerun Settings Malfunction

Randox Laboratories is recalling the RX Daytona Plus (without ISE) IVD Clinical Chemistry Analyzer due to a flaw in rerun settings that may cause incorrect test result reporting.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is an FDA Class II recall for a clinical chemistry analyzer with potential for incorrect test result reporting. No illnesses or injuries have been reported. As a risk-of-harm product where injury has not yet been reported, it meets the rubric criterion for High severity.

Plain-English summary

Randox Laboratories Ltd. is recalling the RX Daytona Plus (without ISE)-IVD Clinical Chemistry Analyzer, models RX4041 and RX4041R (refurbished). A total of 6 units were distributed nationwide in the United States, including Puerto Rico.

The recall addresses a malfunction in the analyzer's parameter rerun settings for sample volume and dilutions. When samples fall outside the assay range, the auto-rerun feature may not function correctly, potentially resulting in incorrect test result reporting.

Users of affected units should contact Randox Laboratories Ltd. or the FDA for instructions. Affected lot numbers are: RX4041 (7241-0616, 7241-0582, 7241-0441, 7241-0425, 7241-0384) and RX4041R (7241-0149).

The recalled product

Product
RX Daytona Plus (without ISE)- IVD Clinical Chemistry Analyser (1) RX4041, (2) RX4041R (refurbished)
Manufacturer
Randox Laboratories Ltd.
Hazard
  • software-error
  • incorrect-result-reporting

Distribution

Distributed nationwide across the United States.